By 2023, it is anticipated that the worldwide cystic fibrosis therapeutics market would be worth US$ 12.5 billion. The market for cystic fibrosis is expected to rise globally at a CAGR of 25.0% between 2023 and 2033, reaching about US$ 116.42 billion by that time, thanks to the advent of cutting-edge treatment options for early …
Category Archives: Healthcare Trends
PD1 Resistant Head and Neck Cancer Market Eyes Striking US$ 5 Billion Horizon by 2033
The PD1-resistant head and neck cancer market sales is predicted to increase at a compound annual growth rate (CAGR) of 12.5%, reaching a valuation of US$ 1.54 billion in 2023 and US$ 5 billion by 2033. The ageing population and initiatives from governmental and non-governmental groups like Support for People with Oral and PD1 Resistant …
Hyperphosphatemia Market Accelerates Towards US$ 20.24 Billion with a 4.8% CAGR Through 2033 | Report By Future Market Insights
Future Market Insights projects that between 2023 and 2033, the hyperphosphatemia market would grow rapidly. The global market for pharmaceuticals treating hyperphosphatemia is predicted to expand at a similar rate by 2033, when sales of these drugs are projected to reach US$ 20.24 billion. Various calcium-based phosphorus binders are being used in the present day …
Global Klinefelter Syndrome Therapeutics Industry on a Trajectory to Reach US$ 1.85 Billion by 2033, Fueled by 5% CAGR | FMI
The Global Klinefelter Syndrome Therapeutics Industry is set to undergo a substantial surge, with a Compound Annual Growth Rate (CAGR) of 5% projected from 2023 to 2033, according to the latest report from Future Market Insights. The market is expected to reach a valuation of US$ 1.85 Billion, marking a significant increase from US$ 1.14 …
Global Durable Medical Equipment Rental Industry Gears Up for 5.7% CAGR, Eyeing US$47 Billion by 2033 | FMI
The Global Durable Medical Equipment Rental Industry is poised for remarkable growth, with revenue expected to soar from US$27 billion in 2023 to an impressive US$47 billion by 2033, according to the latest analysis report by Future Market Insights. The market is anticipated to achieve a Compound Annual Growth Rate (CAGR) of 5.7% during the …
Global Thrombocytopenia Treatment Industry Gears Up for 5.2% CAGR, Aiming to Reach US$ 10 Billion Valuation by 2033 | FMI Insights
In its latest groundbreaking report, Future Market Insights (FMI) anticipates substantial progress for the Global Thrombocytopenia Treatment Industry, projecting a robust Compound Annual Growth Rate (CAGR) ranging from 3.5% to 4.0% between 2023 and 2033. Simultaneously, the global market for thrombocytopenia medication is set to surge with a remarkable 5.2% CAGR during the forecast period. …
Global Chronic Smell and Flavor Loss Treatment Industry Eyes US$ 5850.2 Million Valuation by 2033, Riding on a 6.4% CAGR | Reports FMI
In the year 2023, the Global Chronic Smell and Flavor Loss Treatment Industry is poised to achieve a significant milestone, with a projected value of US$ 3146 million and an impressive Compound Annual Growth Rate (CAGR) of 6.4%. The driving force behind this growth is the relentless progress in healthcare technology, propelling the market towards …
Global Intestinal Fistula Treatment Industry to Hit US$ 46.82 Billion by 2033 with an Exceptional 5.8% CAGR | FMI
The Global Intestinal Fistula Treatment Industry is set to reach unprecedented heights, with a projected valuation of US$ 46.82 Billion by 2033, showcasing a remarkable Compound Annual Growth Rate (CAGR) of 5.8%. This surge is attributed to continuous advancements in drugs and biotechnology, paving the way for transformative treatments in the intestinal fistula landscape. In …
Global Restrictive Cardiomyopathy Treatment Industry to Skyrocket, expected to Hit US$179.08 Million by 2033, Backed by a 6% CAGR | as Revealed by FMI
The Global Restrictive Cardiomyopathy Treatment Industry is on the brink of a substantial surge, with the market size expected to reach US$100 Million in 2023 and poised to accumulate an impressive US$179.08 Million by 2033. This growth trajectory reflects a robust Compound Annual Growth Rate (CAGR) of 6% throughout the forecast period from 2023 to …
Global Rheumatic Heart Disease Management Industry Poised to Exceed US$ 2.04 Billion by 2033, Driven by a Solid 4.5% CAGR | FMI
The Global Rheumatic-Heart Disease Management Industry is poised for a remarkable trajectory, with a projected worth of US$1.31 billion in 2023. According to leading market analysts at Future Market Insights (FMI), the demand for the management of rheumatic heart disease is expected to surge at a Compound Annual Growth Rate (CAGR) of 4.5% between 2023 …